FILE – In this May 2020 photo provided by Eli Lilly, researchers prepare cells to produce possible COVID-19 antibodies for testing in a laboratory in Indianapolis. The drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study suggesting the drug reduced symptoms, the amount of virus and hospitalizations and ER visits for patients with mild or moderate COVID-19. Eli Lilly and Company announced the partial results Wednesday, Oct. 7 in a news release; they have not yet been published or reviewed by independent scientists. Its drug is similar to one that President Donald Trump received on Friday, Oct. 2 from Regeneron Pharmaceuticals Inc. (David Morrison/Eli Lilly via AP, File)
Upstate News Headlines
- Weekend Things to Do: Greenville South Carolina
- Montana trooper rescues driver from car submerged in icy river
- Teen getting back in the saddle after suffering brain injury in bull riding accident
- Videocast: Warming this week
- Anderson elected officials remember County Councilwoman who died from COVID-19 complications
- Vigil for woman dead from gunshot wound outside now-condemned Economy Inn
- Pregnant Bindi Irwin shares tribute to her late father Steve
- Biden to prioritize legal status for millions of immigrants
- No. 18 Virginia routs No. 12 Clemson to stay perfect in ACC
- AnMed Health and Anderson County partner to hold COVID-19 vaccination clinic
- Bumble removed its political views filter after women reported Capitol rioters on the app to FBI
